PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd, Hangzhou City, 310003, China.\', \'Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, 79 Qingchun Rd, Hangzhou City, 310003, China.\', \'Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd, Hangzhou City, 310003, China.\', \'Department of Laboratory Medicine, The First People\'s Hospital of Yancheng City, Yancheng City, 224005, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bcp.14898
?:doi
?:hasPublicationType
?:journal
  • British journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33982806
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.543
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • Interferon-α-2b aerosol inhalation is associated with improved clinical outcomes in patients with coronavirus disease-2019.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all